» Articles » PMID: 38174113

Canonical Transient Receptor Potential Channel 1 Aggravates Myocardial Ischemia-and-reperfusion Injury by Upregulating Reactive Oxygen Species

Overview
Journal J Pharm Anal
Specialty Chemistry
Date 2024 Jan 4
PMID 38174113
Authors
Affiliations
Soon will be listed here.
Abstract

The canonical transient receptor potential channel (TRPC) proteins form Ca-permeable cation channels that are involved in various heart diseases. However, the roles of specific TRPC proteins in myocardial ischemia/reperfusion (I/R) injury remain poorly understood. We observed that TRPC1 and TRPC6 were highly expressed in the area at risk (AAR) in a coronary artery ligation induced I/R model. mice exhibited improved cardiac function, lower serum Troponin T and serum creatine kinase level, smaller infarct volume, less fibrotic scars, and fewer apoptotic cells after myocardial-I/R than wild-type or mice. Cardiomyocyte-specific knockdown of using adeno-associated virus 9 mitigated myocardial I/R injury. Furthermore, deficiency protected adult mouse ventricular myocytes (AMVMs) and HL-1 cells from death during hypoxia/reoxygenation (H/R) injury. RNA-sequencing-based transcriptome analysis revealed differential expression of genes related to reactive oxygen species (ROS) generation in cardiomyocytes. Among these genes, oxoglutarate dehydrogenase-like () was markedly downregulated. Moreover, deficiency impaired the calcineurin (CaN)/nuclear factor-kappa B (NF-κB) signaling pathway in AMVMs. Suppression of this pathway inhibited upregulation and ROS generation in HL-1 cells under H/R conditions. Chromatin immunoprecipitation assays confirmed NF-κB binding to the promoter. The cardioprotective effect of deficiency was canceled out by overexpression of and in cardiomyocytes. In conclusion, our findings reveal that TRPC1 is upregulated in the AAR following myocardial I/R, leading to increased Ca influx into associated cardiomyocytes. Subsequently, this upregulates expression through the CaN/NF-κB signaling pathway, ultimately exacerbating ROS production and aggravating myocardial I/R injury.

Citing Articles

Metabolomics study of APETx2 post-conditioning on myocardial ischemia-reperfusion injury.

Li J, Wei Y, Wang Y, Zhang Y, Xu Y, Ma H Front Pharmacol. 2024; 15:1470142.

PMID: 39712499 PMC: 11658994. DOI: 10.3389/fphar.2024.1470142.


Mettl1 knockdown alleviates cardiac I/R injury in mice by inactivating the Mettl1-CYLD-P53 positive feedback loop.

Yu S, Sun Z, Li N, Qu Z, Wang C, Ju T Acta Pharmacol Sin. 2024; 46(3):592-605.

PMID: 39414959 PMC: 11845720. DOI: 10.1038/s41401-024-01395-5.


Investigating the Mechanistic of Danhong Injection in Brain Damage Caused by Cardiac I/R Injury via Bioinformatics, Computer Simulation, and Experimental Validation.

Wang J, Guo Y, Zhou H, Hua Y, Wan H, Yang J ACS Omega. 2024; 9(16):18341-18357.

PMID: 38680343 PMC: 11044240. DOI: 10.1021/acsomega.4c00200.


Exploring the Potential Mechanisms of Guanxinshutong Capsules in Treating Pathological Cardiac Hypertrophy based on Network Pharmacology, Computer-Aided Drug Design, and Animal Experiments.

Liu Y, Li Q, Shao C, She Y, Zhou H, Guo Y ACS Omega. 2024; 9(16):18083-18098.

PMID: 38680308 PMC: 11044149. DOI: 10.1021/acsomega.3c10009.

References
1.
Weihrauch T, Baumann J, Ebner F . Early treatment of unstable angina in the coronary care unit: a randomised, double blind, placebo controlled comparison of recurrent ischaemia in patients treated with nifedipine or metoprolol or both. Br Heart J. 1988; 59(2):270-2. PMC: 1276997. DOI: 10.1136/hrt.59.2.270. View

2.
Mailloux R, Gardiner D, OBrien M . 2-Oxoglutarate dehydrogenase is a more significant source of O2(·-)/H2O2 than pyruvate dehydrogenase in cardiac and liver tissue. Free Radic Biol Med. 2016; 97:501-512. DOI: 10.1016/j.freeradbiomed.2016.06.014. View

3.
Cadenas S . ROS and redox signaling in myocardial ischemia-reperfusion injury and cardioprotection. Free Radic Biol Med. 2018; 117:76-89. DOI: 10.1016/j.freeradbiomed.2018.01.024. View

4.
Wilkins B, Dai Y, Bueno O, Parsons S, Xu J, Plank D . Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy. Circ Res. 2003; 94(1):110-8. DOI: 10.1161/01.RES.0000109415.17511.18. View

5.
Cartwright E, Mohamed T, Oceandy D, Neyses L . Calcium signaling dysfunction in heart disease. Biofactors. 2011; 37(3):175-81. DOI: 10.1002/biof.149. View